Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT06444607

Hereditary Pheochromocytoma Assessment of Tumour Immunologies

Led by Radboud University Medical Center · Updated on 2024-11-21

200

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In this study, the investigators are examining the role of the immune system in pheochromocytoma and paraganglioma. The investigators aim to examine the differences in the immune system between people who have these tumors with and without a hereditary predisposition. The investigators also want to see how the immune system changes during the development of the tumor in people with a hereditary predisposition. Finally, the investigators will compare the data with a control group of people without these tumors. Ultimately, the investigators hope that the results will contribute to the discovery of new immune system-targeted medications for pheochromocytoma and paraganglioma.

CONDITIONS

Official Title

Hereditary Pheochromocytoma Assessment of Tumour Immunologies

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Newly diagnosed patients with pheochromocytoma or paraganglioma (PPGL) or newly diagnosed patients with metastatic PPGL recurrence
  • Patients with mutations predisposing to PPGL
  • Confirmed PPGL by pathology (for tissue sample study)
  • Aged over 18 years
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Active inflammatory or infectious diseases
  • Other malignancies under active treatment (except basal cell carcinoma and in situ carcinomas)
  • Using medications that affect the immune system
  • Pregnancy or breastfeeding
  • Self-reported alcohol consumption of more than 21 units per week

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Radboudumc

Nijmegen, Gelderland, Netherlands, 6525 GA

Actively Recruiting

Loading map...

Research Team

K

Kai Xu, M.D.

CONTACT

M

Marieke de Laat, M.D. PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here